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The expression of measles virus (MV) in six different permanent human glioma cell lines (D-54, U-251, 
U-138, U-105, U-373, and D-32) was analyzed. Although all celllines were permissive for productive replication 
of all MV strains tested, U-251, D-54, and D-32 cells spontaneously revealed restrictions of MV transcription 
similar to those observed for primary rat astroglial cells and brain tissue. In vitro differentiation of D-54 and 
U-251 cells by substances affecting tbe intracellular cyclic AMP Ievel caused a significant reduction of tbe 
expression of tbe viral proteins after 18, 72, and 144 b of infection. This pronounced restriction was not 
paralleled to a comparable Ievel by an inhibition of tbe syntbesis and biological activity in vitro of virus·specific 
mRNAs as sbown by quantitative Northem (RNA) blot analyses and in vitro translation. The block in viral 
protein syntbesis could not be attributed to tbe induction of type I interferon by any of tbe substances tested. 
Our findings indicate tbat down-regulation of MV gene expression in human brain cells can occur by a cell 
type-rlependent regulation of tbe viral mRNA transcription and a differentiation-dependent regulation of 
translation, botb of wbicb may be crucial for the establisbment of persistent MV infections in tbe centrat 
nervous system. 
Measles virus (MV) has been identified as the etiological 
agent of subacute sclerosing panencephalitis (SSPE) and 
measles inclusion body encephalitis (31). Both diseases 
develop on the basis of a persistent infection of brain cells 
after incubation periods of months to years following pri-
mary infection. Molecular studies demonstrated character-
istic restrictions of viral gene expression in the brain tissue 
of such patients at the Ievel of both accumulation and 
translation of viral mRNAs affecting mainly the envelope 
genes coding for the matrix (M), fusion (F), and hemagglu-
tinin (H) proteins (5, 28). Similar Observations have been 
made in studies of rats with subacute measles encephalitis, 
suggesting that the transcriptional down-regulation of MV 
occurs rather early in infection and is independent of long 
incubation periods (26). However, the mechanisms leading 
to the establishment of viral persistence and prevention of a 
lytic infection of brain cells are largely unknown. 
To analyze further the MV -brain cell interactions, brain 
tissue culture cells are needed, since the complexity of the 
brain itself renders detailed studies in the central nervous 
system difficult. Using MV-infected primary rat astroglial 
cells, we recently confirmed a highly polar expression gra-
dient for MV monocistronic transcripts in comparison with 
infected Vero cells, indicating an inftuence of host cell-
dependent factors on the regulation of MV transcription in 
brain cells (27). For further characterization of these factors, 
however, primary rodent brain cell cultures arenot suitable, 
since they are not natural host cells for MV and are available 
in only limited amounts. Therefore, it was necessary to 
establish a tissue culture system with human cell lines of 
neural origin that would allow us to study the regulation of 
MV transcription in a homologous system. 
In this study we analyzed six MV -infected human glioma 
cell lines and found that three of them revealed transcrip-
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tional down-regulation of MV -specific monocistronic mRNA 
expression like that found in MV -infected human brain 
tissue. Moreover, we evaluated the effect of differentiating 
substances on MV replication in these cells, since it has been 
reported that the state of cell differentiation may inftuence 
MV gene expression (18, 25, 35). On treatment with a variety 
of compounds affecting the intracellular cyclic AMP (cAMP) 
Ievel, two of the human glioma cell lines differentiated and 
expressed glial cell-specific mRNAs. In these two celllines, 
pretreatment with 10 ...,M papaverine led to a drastic reduc-
tion of both virus release and synthesis of the virus-specific 
proteins. The steady-state Ievels of the corresponding 
mRNAs and their ability to translate in vitro were mostly 
unaffected, whereas translation in vivo was almost com-
pletely inhibited. Our data indicate that in contrast to the 
situation with nonneural cells, MV transcription can be 
down-regulated in human glioma cells by intrinsic host cell 
factors, whereas the translation of virus-specific proteins is 
inftuenced by the state of differentiation of the brain cells. 
MATERIALS AND METHODS 
Cells and viruses. Human glioma cell lines D-54, D-32, 
U-138, U-105, U-251, and U-373 were kindly provided by D. 
Bigner (4, 34). All cell lines were cultured in Dulbecco 
minimal essential medium containing 10% inactivated fetal 
calf serum FCS. Vero (African green monkey) and HEL 
(human embryonie lung fibroblast) cells were grown in 
minimal essential medium containing 5% FCS. MV strains 
(vaccine strain Edmonston; neurotropic strain CAM/RBH 
[15]; wild-type strains Braxator, Woodfolk, and EVA; and 
SSPE isolates Lee, Halle, and Mantooth) were passaged and 
subjected to titer determination on Vero cells. 
Treatment of cells witb differentiating agents. Conftuent 
monolayers were pretreated for the times indicated with 
AMP, cAMP, dibutyryl-cAMP, 8-bromo-cAMP, 8-(4-chlo-
rophenylthio-cAMP) (CPT -cAMP), forskolin, isobutylmeth-
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T ABLE 1. MV replication in human glioma cell lines and nonneural controls" 
MV replication in: 
Time p.i.b Vero HEL U-105 U-373 U-138 U-251 D-54 D-32 (h) 
%C PFUd % PFU % PFU % PFU % PFU % PFU % PFU % PFU 
72 95 1 X 107 75 4 X lOS 75 1 X lOS 80 5 X 104 85 5 X 104 60 2 X 104 so 2 X 1Q4 20 5 X 101 
144 NDe ND 100 5 X 106 100 1 X 106 100 1 X 1Q6 100 4 X lOS 100 1 X 106 100 1 X lOS 80 4 X 103 
" Cells were grown in duplicate assays on coverslips and infected with the Edmonston strain of MV (MOl, 0.05). After 72 and 144 h, respectively, supematants 
were harvested and subjected to titer determination on Vero cells. Coverslips were fixed and stained by indirect immunofluorescence with an anti·MV 
hYferimmune serum, and the percentage of MV-positive cells was determined. 
p.i., postinfection. 
c: Percentage of infected cells. 
d PFU per milliliter (results are means from two independent experiments). 
e ND, not done because cells were completely lysed. 
ylxanthine (IBMX), or papaverine at concentrations ranging 
from 10 JJ.M to 1 mM. All substances were purchased from 
Sigma. Following infection with MV, the reagents were 
added fresh to the supematants. 
Immunostaining of MV-infected cells. lndirect-immunoftu-
orescence analysis was performed on acetone-fixed MV-
infected cells previously grown on coverslips by using a 
polyclonal rabbit anti-MV serum or monoclonal antiborlies 
against MV N, M, F, and H proteins. As second antibodies, 
ftuorescein-conjugated anti-rabbit or anti-mouse immuno-
globulins (Dianova) were applied. For ftuorescence-acti-
vated cell sorter analysis, cells were fixed with 0.5% 
paraformaldehyde and permeabilized with phosphate-buff-
ered saline containing 4 mg of n-octyl-ß-o-glucopyranoside 
(Sigma) permlas described previously (16). 
RNA extraction, Northem (RNA) blots, and in vitro trans-
lation. For RNA extraction, 5 x 107 cells were lysed in 4 M 
guanidinium isothiocyanate buffer and RNA was purified by 
centi-ifugation through a CsCl cushion, enriched for poly(A) 
RNA by one cycle of oligo( dT) selection, and analyzed for 
MV -specific monocistronic transcripts as described previ-
ously (26). cDNA probes specific for rat glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (11), rat myelin basic 
protein (MBP) (24), and mouse adhesion molecule on glial 
cells (AMOG) (21) were used as gel-purified fragments and 
Iabeted by random priming with [32P)dCTP as specified by 
the manufacturer (Boehringer, Mannheim, Germany). Hy-
bridization with the DNA probes was performed at 45°C 
followed by three wash steps in 0.25 x SSC (1 x SSC is 0.15 
M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl 
sulfate (SDS) at 68°C. Each 1-J.t.g portion of the isolated 
poly(A)-enriched fractions was translated in vitro in the 
presence of 30 JJ.Ci of [35S]methionine in a rabbit reticulocyte 
lysate (Promega). MV-specific proteins were immunoprecip-
itated from total translation products by using a polyclonal 
rabbit anti-MV serum. 
Metabolie labeling, preparation of cell extracts, and immu-
noprecipitation. Cells (3 x 106) were pretreated at approxi-
mately 75% conftuency with 10 JJ.M papaverine for the 
indicated times prior to infection with MV and were Iabeted 
immediately or after various incubation periods. For label-
ing, cells were starved in methionine-free Dulbecco minimal 
essential medium for 1 h and subsequently Iabeted with 0.5 
mCi of [35S)methionine per ml for 2 h. Total-eeil extracts 
were prepared following Iysis in RIP A detergent (150 mM 
NaCl, 10 mM Tris-HCI [pH 7.4), 1% sodium desoxycholate, 
1% Triton X-100, 1% SDS, 10 mM phenylmethylsulfonylftu-
oride ), incorporation was measured by liquid scintillation 
counting of trichloroacetic acid-precipitable material, and 
the protein content was determined by Standard procedures 
(Sigma). Both equal counts and equal amounts of protein 
were immunoprecipitated when using rabbit anti-MV serum 
and separated by SDS-polyacrylamide gel electrophoresis 
(PAGE) (10% polyacrylamide). 
Western blot analysis. Unlabeled extracts were prepared 
as described above in RIPA detergent. Each 20-._.,g portion 
of total-eeil extract was separated by PAGE (10% poly-
acrylamide) and transferred to nitrocellulose by semidry 
blotting. Western immunoblots were stained with a mono-
clonal anti-human MxA antibody (kindly provided by M. A. 
Horisberger [13]) and with a peroxidase-conjugated rabbit 
anti-mouse immunoglobulin as the second antibody and 
developed with chloronaphthol in the presence of H20 2• 
RESULTS 
Replication of MV in human glioma cell lines and control 
cells. To characterize MV replication in cells of neural origin, 
six human glioma cell lines (U-105, U-373, U-138, U-251, 
D-54 and D-32) and, as controls, two celllines of nonneural 
origin (Vero and HEL) were infected with the Edmonston 
strain of MV (multiplicity of infection [MOl], 0.05). Cells 
and supematants were harvested at 72 and 144 h following 
infection to determine the percentage of infected cells and 
the titer of infectious virus. All neural cell lines tested 
allowed replication of MV and revealed a cytopathic effect. 
Most of them, however, produced less infectious virus than 
the control celllines did (Table 1). In particular, in D-54 and 
D-32 cells the yield of infectious virus was reduced by a 
factor of more than 10Z and 103, respectively, compared with 
Vero cells. Similar results were obtained with several differ-
ent strains of MV including the wild-type isolates Braxator, 
EVA, and Woodfolk; the SSPE isolates Lee, Halle, and 
Mantooth; and the neurotropic strain CAM/RBH. Since our 
results were independent of the input virus, further experi-
ments were carried out with MV Edmonston. 
The polyadenylated RNA fractions of the six human 
glioma celllines and the control celllines and the control cell 
lines infected with MV (MOl, 0.05) for 24, 48, 72 and 96 h 
were analyzed for the steady-state Ievels of MV -specific 
monocistronic transcripts by using quantitative Northem 
blots. The overall expression Ievels of MV -specific RNAs 
were reduced in all neural cell lines to about 13 to 60% of 
those found in Vero and HEL cells as determined by the 
expression of the N-specific mRNA after 24 h (Fig. la). 
Furthermore, as shown representatively for 72 h postinfec-
tion, the transcription gradients obtained for the monocis-
tronic MV transcripts differed among the individual celllines 
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FIG. 1. Steady-state Ievel of MV-specific monocistronic mRNAs 
in human glioma cells and nonneural controls. Poly(A)+ RNA was 
isolated from six human glioma celllines and from Vero and HEL 
cells infected with 0.05 PFU of MV per cell for 24 h (panel a) and 72 
h (panel b) and analyzed by quantitative Northern blots with 
[ 32P]CfP-Iabeled RNA probes specific for each individual MV gene 
except L (6, 7). Signals corresponding to synthetic standard RNA 
transcripts and individual monocistronic MV-specific mRNAs were 
excised, and the radioactivity retained was determined by liquid 
scintillation counting. Concentration of the RNA samples was 
controlled by GAPDH hybridization. (a) Expression frequency of 
MV N gene-specific mRNA 24 h following infection indicated as 
copy number per 10 pg of total RNA. (b) Relative expression 
frequencies of individual MV -specific mRNAs 72 h following infec-
tion compared with the individual N gene transcript (N was set to 
100%). 
(Fig. 1b). In all neural celllines tested, the relative expres-
sion frequencies of the glycoprotein-specific mRNAs were 
reduced compared with those found in nonneural cells. 
Again, compared with the nonneural cells, the relative 
frequencies of the M-specific transcripts were reduced in 
D-54, D-32, and U-251 cells but not in U-105, U-373, or 
U-138 cells. These results indicate that host factors intrinsic 
to human cell lines of neural origin are capable of regulating 
MV transcriptional efficiency, as observed previously in 
a. 
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FIG. 2. Induction of glial cell-specific mRNAs in in vitro differ-
entiated D-54 and U-251 cells. Celllines were treated as indicated in 
the text or with 10 1-1-M papaverine for 72 h. RNA (10 ll-8 per lane) 
was separated on 1% formaldehyde-containing agarase gels and 
hybridized to cDNA probes specific for rat MBP (panel a) and 
mouse AMOG (panel b). (a) Lanes: 1, D-54 untreated; 2, D-54 
treated with 10 1-1-M papaverine. The specific signal of 2.2 kb is 
indicated by an arrowhead, and cross-hybridization with 28S RNA 
is indicated by a triangle. (b) Lanes: 1, U-251 untreated; 2, U-251 
treated with 200 ILM CPT-cAMP; 3, U-251 treated with 10 1J.M 
papaverine. Specific signals of 3.6 and 3.0 kb are indicated by 
arrowheads. 
brain tissue from SSPE patients and experimentally MV-
infected rats and primary rat astroglial cells (6, 7, 26, 27). 
In vitro ditl'erentiation of neural cells. To investigate the 
effect of in vitro differentiation of our neural celllines on MV 
gene expression, we treated these and the control celllines 
with compounds that inftuence intracellular cAMP Ievels (1 
mM AMP, 1 mM cAMP, 1 mM dibutyryl-cAMP, 1 mM 
8-bromo-cAMP, 200 ~M CPT-cAMP, 10 ~M forskolin, 1 
mM IBMX, 10 JLM papaverine). As observed previously, 
various extents of morphological changes could be observed 
in all glioma cell lines following treatment with these sub-
stances (4, 34). To confirm differentiation, we prepared RNA 
from all cell lines at 72 h after treatment with the various 
substances and analyzed it for the expression of brain 
cell-specific mRNAs by Northem blotting. Only in two celJ 
lines, D-54 and U-251, could the induction of these mRNAs 
be detected. Treatment of D-54 with 10 ~M papaverine 
induced low Ievels of a 2.2-kb transcript specific for MBP, a 
marker for oligodendrocytes (Fig. 2a, lane 2) (24). A slight 
cross-hybridization of this probe with 28S RNA also ap-
peared in untreated cells (Fig. 2a, lane 1). In U-251 cells 
treated with 10 tJ.M papaverine or 200 J.LM CPT-cAMP, two 
major mRNA species of about 3.6 and 3.0 kb (Fig. 2b, lanes 
2 and 3) were induced that were specific for the mRNA of 
AMOG, a marker for astrocytes (21). Treatment with all the 
other compounds listed above did not Iead to the expression 
of MBP- or AMOG-specific transcripts in either cell line 
(results not shown). The inducibility of MBP in D-54 cells 
indicates that these cells are probably of the oligodendrocyte 
lineage, whereas U-251 cells, which express the glial fibril-
lary acidic protein (4), are astrocytoma cells. No induction of 
these mRNAs appeared in the other glioma cells or the 
control celllines (results not shown). 
Replication of MV in in vitro dift'erentiated glial celts. To 
analyze MV gene expression in in vitro differentiated neural 
cells, we studied D-54 and U-251 cells since both celllines 
could be differentiated in vitro with papaverine (see above ). 
Pretreatment of both neural celllines with 10 JLM papaverine 
for 48, 24, and 3 h prior to MV infection (MOl, 0.05) reduced 
the titers of infectious virus after 72 and 144 h by up to 4 log 
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TABLE 2. Influence of in vitro differentiation on the production of infectious MV in cells of neural and nonneural origina 
Time (h before 
MV productionb (PFU/ml) in: 
infection) of U-251 D-54 Vero HEL 
treatment 
72h 144 h 72h 144 h 72h 144 h 72h 144 h 
None 1 X 104 6 X lOS 1 X 104 4 X lOS 6 X 106 NDC 1 X lOS 2 X 106 
48 2 X 101 1 X 101 1 X 101 1 X 101 1 X 107 ND 6 X 104 4 X 105 
24 1 X 101 3 X 102 2 X 101 1 X 101 5 X 106 ND 2 X lOS 5 X lOS 
3 1 X lQl 2 X lQl 4 X 101 1 X 102 1 X 107 ND 6 X 104 2 X 105 
0 3 X 1(}3 2 X 1(}3 3 X lQl 1 X 1(}3 1 X 107 ND 2 X lOS 1 X 106 
a Cells were pretreated with 10 ILM papaverine for the time intervals indicated or left untreated and infected with MV at 0.05 PFU per cell for 72 and 144 h. 
Supematants were harvested, and their titers were deterrnined on Vero cells. 
b Values are means from two independent experiments. 
c ND, not done (cells were destroyed). 
units compared with the untreated controls. Treatment of 
cells with papaverine simultaneously with the infection was 
less effective (Table 2). No significant inftuence on the virus 
yield could be observed in papaverine-treated Vero and 
HEL cells (Table 2). 
In addition, we could show by immunoftuorescent staining 
with polyclonal sera and monoclonal antiborlies that after 
pretreatment of D-54 and U-251 cells with 10 ~M papaverine 
for 48 h, the expression of the major MV structural proteins 
was reduced to almost undetectable Ievels 72 and 144 h 
following infection (results not shown). 
Steady-state Ievel of MV -specific RNAs in in vitro dift'eren-
tiated human glioma cells. To determine the basis for the 
restrictions of MV replication that we observed, we ana-
lyzed the frequency of MV -specific transcripts in undiffer-
entiated or differentiated D-54 and U-251 cells after 72 and 
144 h of infection by using quantitative Northern blots with 
poly(A)-enriched RNA fractions (Table 3). Differentiation 
was induced by pretreatment with 10 ~M papaverine for 48 
h prior to infection. Equal amounts of RNA were blotted in 
all experiments as controlled by a GAPDH hybridization 
(results not shown). For D-54 cells, no significant differences 
in the Ievels of monocistronic MV -specific transcripts could 
be observed after 72 h in differentiated and undifferentiated 
cells, except that the mRNA gradient from N to H appeared 
tobe slightly steeper in differentiated cells (Table 3). After 6 
days of infection, however, the total amount of MV-specific 
mRNAs was reduced by more than 50% compared with that 
in the untreated control as monitored by the frequency of 
N-specific transcripts, whereas the gradient remained sub-
stantially stable (Table 3). For U-251 cells, a reduction in the 
Ievel of the MV N-specific mRNA was already apparent 
after 72 h (50% of control Ievels), and by 144 h following 
infection, a steep gradient of transcription similar to that in 
D-54 cells was established (Table 3). 
To assess the biological activity of the isolated mRNAs, 
we performed in vitro translation experiments (Fig. 3, lanes 
1 to 7). Following immunoprecipitation of the translation 
products, the N, P, and M proteins (M migrating as double 
band) were detected in the undifferentiated D-54 and U-251 
cells andin Vero cells (lanes 8, 9, and 12). Fand H proteins 
usually cannot be detected in these assays because of the 
low expression Ievels of the corresponding mRNAs and the 
Iack of antiborlies that would recognize the proteins synthe-
sized in vitro. Following differentiation of D-54 cells by 10 
~M papaverine for 24 and 48 h prior to infection, the 
biological activity of the MV -specific mRNA fractions iso-
lated after 72 h of infection (lanes 10 and 11) was not altered 
compared with that of the untreated control cells (lane 9). 
Poly(A)+ RNA isolated from differentiated U-251 cells ap-
peared to direct the synthesis of slightly lower Ievels of 
MV -specific proteins, in particular M protein, in vitro com-
pared with the untreated control (lanes 12 and 14). This 
finding might be because at the same time the relative 
amount of MV -specific transcripts was reduced by 50% in 
differentiated U-251 cells compared with the undifferentiated 
control (Table 3). 
Thus, in vitro differentiation of U-251 but not of D-54 cells 
TABLE 3. Quantitativeanalysis of MV-specific transcription in in vitro differentiated and undifferentiated D-54 and U-251 cellsa 
Frequency (copies/cell) of MV-specific transcripts (%) inb: 
D-54 U-251 
Protein Vero, 
untreated, Untreated 10 ILM papaverine Untreated 10 11-M papaverine 
72h 
72h 144 h 72h 144 h 72h 144 h 72h 144 h 
N 19,700 (100) 6,000 (100) 4,800 (100) 6,700 (100) 2,000 (100) 7,000 (100) 6,800 (100) 3,400 (100) 2,700 (100) 
p 15,500 (78) 3,800 (63) 4,000 (80) 5,200 (77) 1,500 (75) 3,200 (46) 4,600 (68) 2,500 (74) 1,700 (64) 
M 11,000 (56) 2,000 (34) 1,550 (33) 1,430 (21) 500 (25) 2,400 (35) 3,000 (44) 1,600 (47) 600 (21) 
F 8,500 (43) 1,500 (26) 800 (17) 700 (10) 330 (16) 1,400 (20) 1,000 (15) 800 (24) 110 (4) 
H 6,300 (32) 500 (8) 500 (12) 400 (6) 345 (17) 700 (10) 900 (14) 600 (17) 100 (4) 
a Cells were pretreated with 10 ILM papaverine for 48 h or left untreated; they were then infected with 0.05 PFU of MV per cell. Poly(A)+ RNA fractions were 
harvested 72 and 144 h later, and a mixture of synthetic standard RNA transcripts was separated on 1.5% agarose gels, blotted, and hybridized as described 
previously (27). Signals corresponding to the monocistronic MV -specific mRNAs and the synthetic standard RNA transcripts were excised, and radioactivity 
retained was deterrnined by scintillation counting. 
b Values shown as copies/cell indicate the absolute copy number per transcript for one infected cell (roughly for 10 pg of RNA), and the percentages indicate 
the relative expression frequencies with respect to the transcription frequency of the individual N gene transcript (N = 100% ). 
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FIG. 3. In vitro translation of mRNAs isolated from in vitro 
differentiated and undifferentiated D-54 and U-251 cells. Each 1 ~g 
of poly(A)+ RNA isolated from in vitro differentiated or undifferen-
tiated D-54 and U-251 cells 72 h following infection with 0.05 PFU of 
MV per cell was translated in vitro in the presence of [35S]methio-
nine (lanes 1 to 7). MV-specific proteins were precipitated from the 
total translation products by an MV hyperimmune serum and 
separated by PAGE (10% polyacrylamide) (lanes 8 to 14). Lanes: 1 
and 8, lytically infected Vero cells; 2 and 9, D-54 cells untreated; 3 
and 10, D-54 cells differentiated with 10 ~M papaverine for 24 h; 4 
and 11, D-54 cells differentiated with 10 ~M papaverine for 48 h; 5 
and 12, U-251 cells untreated; 6 and 13, U-251 cells differentiated 
with 10 ~M papaverine for 24 h; 7 and 14, U-251 cells differentiated 
with 10 ~M papaverine for 48 h. 
was accompanied by quantitative transcriptional alterations 
of MV-specific mRNAs 72 h following infection. Since an 
inhibition of the biological activity of these MV -specific 
mRNAs could not be observed in vitro, the significant 
down-regulation of MV replication observed for both cell 
lines in vivo must be caused by additional mechanisms. 
Translation ofMV-specific proteins in in vitro ditferentiated 
glial cells. To monitor MV -specific protein synthesis in 
diflerentiated neural cells, we pretreated D-54 and U-251 
cells with papaverine for 48 h, infected them with MV (MOl, 
0.05), and labeled them with [35S]methionine after various 
times up to 144 h following infection. Total lysates were 
immunoprecipitated by using a polyclonal MV hyperimmune 
serum. In untreated D-54 and U-251 cells, MV N, P, M, and 
H proteins could be detected after 72 and 144 h of infection 
(Fig. 4a and c). In lysates prepared from cells pretreated with 
papaverine for 48 h, hardly any MV -specific proteins could 
be found (Fig. 4b and d). This eflect appeared tobe specific 
for MV proteins, since no eflect on total-protein synthesis 
was evident in unprecipitated lysates (results not shown). 
Thus, a specific, diflerentiation-dependent inhibition of MV 
protein synthesis in the presence of significantly large 
amounts of MV-specific mRNAs (Table 3) was apparent in 
neural cells. 
To release the diflerentiation-dependent block and to 
reactivate translation from the accumulated MV-specific 
transcripts, U-251 cells we pretreated as described above 
and, after infection for 72 h with MV (MOl, 0.05), papaver-
ine was removed for 6 h and cells were labeled with 
[35S]methionine forafurther 2 h. Following immunoprecip-
itation, MV N-specific signals were quantified by phosphor-
imaging. Pretreatment with papaverine led to a drastic 
reduction of MV N-specific protein synthesis by 90% com-
pared with control cells (Fig. 5, lanes 2 and 4). At 6 h 
following removal of the diflerentiation medium, an approx-
imately fivefold increase in the expression of N protein could 
be observed (lane 3). The expression Ievel obtained for N 
protein under these conditions was about 50% of that 
achieved after a primary infection for 6 h with MVat an MOl 
a. b. 
1 2 3 4 5 1 2 3 4 5 Ma 
c. d. 
1 2 3 4 5 12345Ma 
-200 
-92 
-69 
-cN 
-46 
FIG. 4. In vivo synthesis of MV-specific proteins in in vitro 
differentiated and undifferentiated D-54 and U-251 cells. D-54 (pan-
els a and b) and U-251 (panels c and d) cells were pretreated for 48 
h (panels b and d) with 10 ~M papaverine or Jeft untreated (panels a 
and c) and infected with MV (MOl, 0.05). lmmediately following 
infection (lanes 1) or 3 h (lanes 2), 6 h (lanes 3), 72 h (lanes 4), or 144 
h (lanes 5) after infection, cells were Iabeted for 2 h, and totallysates 
were prepared and immunoprecipitated with MV hyperimmunese· 
rum. Proteins were separated by PAGE (10% polyacrylamide ). 
Lanes Ma contain 14C-methylated protein size markers. 
of 5 (lane 1). Given the short time and the extremely low 
Ievel of infectious MV present in the medium under these 
conditions (Table 2), the increase in MV protein expression 
following removal of the differentiation medium reftects a 
release of the translational block of accumulated viral 
mRNAs. 
Inhibition of primary MV gene expression in ditferentiated 
glial cells. To investigate whether the diflerentiation-depen-
dent block in viral protein synthesis in the presence of 
ongoing transcription can be observed under conditions 
other than several days after infection with low-input MOls, 
we assessed the eflects of in vitro diflerentiation on primary 
MV gene expression by using higher MOl. As exemplified 
for U-251 cells, parallel cultures untreated or pretreated with 
10 ~M papaverine for 48 h were infected with MV at an MOl 
of 1 for 18 h and analyzed for the steady-state Ievel of MV 
N-specific mRNA and MV-specific protein expression in 
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1 2 3 4 
FIG. 5. Reactivation of MV protein synthesis following removal 
of the differentiation medium. U-251 cells were pretreated with 10 
~M papaverine for 48 h (lanes 2 and 3) or left untreated (lanes 1 and 
4). Cells were infected with an MOl of 0.05 (lanes 2 to 4). After 72 
h, the differentiation medium was removed, cells were washed 
carefully, and infection was allowed to proceed for a further 6 h 
(lane 3). For a control, U-251 cells were infected with an MOl of 5 
for 6 h (lane 1). Following a 2-h labeling period with [35S]methionine, 
lysates were prepared and immunoprecipitated with an anti-MV 
hyperimmune serum. Proteins were separated by PAGE (10% 
polyacrylamide). The MV N-specific signals were quantitated with a 
phosphorimager. 
vivo. Comparable amounts of N-specific mRNA were ex-
pressed in undifferentiated (Fig. 6a, lane 1) and differentiated 
(Fig. 6a, lane 2) U-251 cells. The apparently slightly weaker 
signal for the N monocistronic and NP bicistronic RNA in 
differentiated U-251 cells (Fig. 6a, lane 2) is because not 
exactly equal amounts of total RNA were applied for gel 
analysis as controlled by GAPDH hybridization (Fig. 6a, 
bottom panel). A quantitative analysis of MV -specific pro-
tein expression at the same time, however, revealed that the 
Ievels of MV -specific protein expression in differentiated 
U-251 cells were reduced to 25% for N proteins and to 13% 
for H and M proteins of the untreated controls (Fig. 6b ). 
Reliable data on virus release even in the untreated control 
cells could not be obtained because of the short duration 
of infection. These data indicate that in differentiated cells 
a. b. 
FIG. 6. Effect of in vitro differentiation on primary MV gene 
expression. Parallel cultures of U-251 cells were pretreated with 10 
~M papaverine for 48 h (lanes 2) or left untreated (lanes 1) and 
infected with MV at an MOl of 1 for 18 h. The signals obtained were 
quantitated by phosphorimaging. (a) Each 15 ~g of total cellular 
RNA was hybridized to a MV N-specific (upper panel) or GAPDH-
specific (bottom panel) probe. N-mono, N-specific monocistronic 
RNA; NPbi, NP bicistronic RNA. (b) Immunoprecipitation of 
MV-specific proteins labeled after 18 h of infection with an MOl of 
1. 
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FIG. 7. lnduction oftype I IFN in D-54 cells. (a) D-54 cells were 
cultured without additives (lane 1) or treated for 18 h with 500 U of 
human IFN-ß (lane 2) or for 48 h with 10 ~M papaverine (lane 3) or 
200 ~M CPT-cAMP (lane 4). Each 20 11-g of protein extract was 
separated by PAGE (10% polyacrylamide), blotted onto nitrocel· 
lulose filters, stained with a monoclonal antibody against human 
MxA (p78) (13), and developed with H20 2• (b) D-54 cells were 
cultured without additives (lanes 2 and 6) or pretreated for 48 h 
with 200 ~M CPT-cAMP (lanes 3 and 7), 10 ~M papaverine (lanes 4 
and 8), or 1 mM dibutyiyl-cAMP (lanes 5 and 9) prior to infection 
with MV (MOl, 0.05). Protein extracts were prepared after 24 h 
(lanes 2 to 5) or 48 h (lanes 6 to 9) of infection. Lane 1 contains 
extract from uninfected D-54 cells. Each 50 ~g of total cell extract 
was separated by PAGE (10% polyacrylamide ), blotted, and stained 
forMxA. 
of neural origin the synthesis of MV -specific proteins but not 
of mRNAs is already inhibited within the first replication 
cycle. 
Restrietion of MV -specific protein synthesis in glial cells is 
not Unked to type I IFN. To assess the possibility that the 
virus-specific restriction of protein synthesis was due to the 
induction of type I interferon (IFN) by papaverine in D-54 
and U-251 cells, supematants of papaverine-treated cells 
infected or uninfected with MV were assayed for type I IFN. 
No evidence for type I IFN induction could be obtained in a 
vesicular stomatitis virus (VSV) bioassay. Therefore, as a 
more sensitive test system for IFN synthesis, the intracellu-
lar induction of the human MxA protein was analyzed by 
·Western blotting. Except for the positive control performed 
with recombinant IFN-p, MxA was not induced by any of 
the compounds applied, as exemplified for D-54 cells (Fig. 
7a, lane 2). MV infection itself induced significant amounts 
of MxA within 24 and 48 h in both cell lines independent of 
the pretreatment with papaverine or CPT-cAMP (shown for 
D-54 in Fig. 7b ). In addition, the induction of MxA in both 
cell lines following infection with MV could be blocked by 
about 60% in the presence of anti-IFN-P antibodies (data not 
shown). Thus, MV infection induced type I IFN which was 
not detectable in the VSV bioassay but was clearly deman-
strabte in the MxA induction assay. Therefore, the observed 
restriction of MV -specific protein synthesis was not due to a 
hyperinduction of type I IFN by papaverine or CPT -cAMP 
treatment of glioma cells but appears to result from different 
mechanisms. 
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DISCUSSION 
Host cell-dependent down-regulation of MV gene expres-
sion may be crucial for the establishment of persistent 
infections in human brain tissue (5, 28). Transcriptional 
regulation of MV -specific monocistronic mRNAs Ieading to 
highly polar transcription gradients have been described for 
brain tissue from patients with SSPE and for experimentally 
induced central netvous system infections in rats and in 
tissue cultures with primary rat astroglial cells (6, 7, 26, 27). 
We now provide experimental evidence that this particular 
regulation and a down-regulation of MV protein synthesis 
occur in an experimental system involving homologous 
human cells of neural origin, indicating that factors intrinsic 
to the host cell do affect MV expression. 
As shown previously for primary rat astroglial cells (27), 
the Ievel of viral transcripts as measured by the expression 
of the N-specific mRNA was found to be reduced during 
infection in all neural cell lines compared with that in Vero 
and HEL cells (Fig. 1a). Since we used low MOls for the 
experiments, the neural celllines show a reduced capacity to 
replicate MV, which might be due to a lower activity of the 
viral transcription complex. As found typically in brain 
tissue, transcription of the glycoprotein-specific mRNAs 
was significantly attenuated in all the neural celllines. These 
findings indicate that the analysis of brain cell-specific fac-
tors regulating MV transcription can be addressed in the 
future by using permanent human cell lines. 
Mx proteins have been shown to interfere with inftuenza 
virus and VSV replication (17, 22, 29). Recently, a down-
regulation of VSV transcription accompanied by the estab-
lishment of a more polar transcription gradient for monocis-
tronic transcripts in stably MxA-transfected Swiss 3T3 cells 
has been obsetved (30). Interestingly, we could detect a 
differentiation-independent induction of type I IFN, most 
probably IFN-ß, and the IFN-inducible MxA protein on MV 
infection in D-54 and U-251 cells (Fig. 7b). In addition, high 
Ievels of Mx proteins were found in MV -infected primary rat 
astroglial cells (16). Whether MxA protein contributes to 
transcriptional or translational regulation of MV remains to 
be investigated. 
In our experiments, we analyzed a variety of substances 
affecting the intracellular cAMP Ievel of tissue culture cells 
for their inftuence on MV replication. In general, membrane-
permeable analogs of cAMP and phosphodiesterase inhibi-
tors such as IBMX and papaverine revealed an inhibitory 
effect. Papaverine, a potent inhibitor of a variety of phos-
phodiesterases (23), bad been previously shown to inhibit 
the replication of MV (18, 35) and human immunodeficiency 
virus (33) but not herpes simplex virus type 1 or VSV (18). 
Elevation of the intracellular cAMP concentration, which is 
coincident with differentiation, also led to a down-regulation 
of viral gene expression of mouse hepatitis virus JHM in 
explanted rat oligodendrocytes (3). 
A complete inhibition of MV transcription following treat-
ment with papaverine has been described in human neuro-
blastoma IMR 32 cells (35). In contrast, our data suggest that 
translation, not transcription, is the primary target for down-
regulation of MV gene expression following in vitro difler-
entiation in D-54 and U-251 cells. We found that papaverine 
treatment was already inhibiting the translation of MV-
specific proteins after 18 h of infection (Fig. 6b). These 
alterations of translation were obsetved in the presence of 
equal amounts of viral mRNAs in the cultures and within a 
short time, indicating that they occur independently of virus 
spread. The down-regulation of transcription obsetved at 72 
and 144 h following infection may be a consequence of the 
low synthesis of MV proteins essential for viral transcrip-
tion, replication, and, ultimately, spread. 
Following papaverine treatment, a reduced synthesis of all 
MV structural proteins in 118-MGC cells (35) and a selective 
disappearance of MV M protein in mouse N2A and human 
TE671 cells (18) was obsetved, whereas pretreatment of 
human A V3 cells with cAMP led to a reduced synthesis of 
MV P and M proteins (25). · Although no analyses on the 
expression of virus-specific mRNAs have been performed, 
those experiments clearly indicate that a complete inhibition 
of transcription did not occur. This applies in particular to 
the selective disappearance of P and M proteins that are 
translated from mRNAs located upstream of the MV glyco-
protein genes, whereas F and H were still expressed at 
normal Ievels (18, 25). The obvious discrepancy of these and 
our findings to the complete inhibition of MV-specific tran-
scription in human neuroblastoma IMR-32 cells is still un-
solved. In view of the fact, however, that the distribution of 
cAMP-dependent protein kinases as well as phosphodi-
esterases is highly cell type specific (2), extemal treatment 
with compounds affecting the intracellular cAMP Ievel could 
have variable effects on MV gene expression. 
Selective inhibition of viral protein synthesis in vivo has 
been studied intensively for the IFN-inducible P1 kinase (14, 
29, 32), which is activated on autophosphorylation and 
inactivates the a-subunit of translation initiation factor eiF-2 
by phosphorylation (14). Type I IFN was induced on MV 
infection in both cell lines analyzed, as shown by the 
induction of MxA protein. This induction, however, was not 
enhanced by papaverine treatment in infected cells, nor was 
papaverine alone able to induce type I IFN in either cellline 
(Fig. 7). Although it could be shown that the activity of Pl 
kinase can be modulated by extemal stimuli others than IFN 
(10), it has been shown to be completely independent of 
cAMP (1). 
The reason for the failure of MV -specific mRNAs to direct 
the synthesis of structural proteins in vivo in differentiated 
cells is not known. A selective translational inhibition bad 
been described for MV M and F mRNAs after a temperature 
shift in vivo, although these mRNAs retained their biological 
activity in a cell-free translation system (19, 20). lt is 
possible that the interaction of the mRNAs with the cy-
toskeleton, which seems to be crucial for efficient transla-
tion (8) in vivo, is dependent on stress or differentiation 
factors. 
Furthermore, functions of the viral polymerase essential 
for processing and maturation of the viral transcripts might 
be impaired in in vitro diflerentiated cells. Defects in poly-
adenylation would not be expected, since the polyadeny-
lated fraction of RNAs isolated from in vitro differentiated 
D-54 and U-251 cells was biologically active in directing the 
synthesis of MV-specific proteins in vitro (Fig. 4) corre-
sponding to the abundance of MV -specific mRNAs (Table 
3). We cannot rule out the possibility, however, that capping 
modifications did occur, since the in vitro translation system 
is able to translate most mRNAs independent of cap struc-
tures. In fact, it could be shown for a host range polymerase 
mutant of VSV that cap-methylation-defective transcripts 
were translated correctly in vitro but not in vivo in the 
nonpermissive cell line (12). In that case, however, the 
efficiency of in vitro translation for the underrnethylated 
transcripts was significantly lower than that of the com-
pletely methylated mRNAs. Although the amounts of MV-
specific transcripts synthesized in our experiments in vitro 
from polyadenylated mRNAs from differentiated and undif-
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ferentiated glial cells after 72 h seemed tobe identical, we 
cannot rule out the possibility that the commercial in vitro 
translation system we used is not as sensitive to this effect as 
was the system used for the VSV study. As an example of 
translational control of viral mRNAs exerted by the host 
cell, the interaction of picornavirus mRNA with cellular 
proteins that facilitate cap-independent internal initiation of 
translation has recently been described (9). 
These findings suggest that a particular host cell may 
contain the necessary components to regulate the transla-
tional efficiency of viral transcripts. Control at the Ievel of 
MV -specific translation exerted by the infected brain cell 
would provide a highly potent mechanism to down-regulate 
MV gene expression in vivo. Taken together, our findings 
indicate that differentiated brain cells may be able to down-
regulate viral transcription as weil as viral translation. Both 
mechanisms might contribute to the establishment of persis-
tent MV infections of the central nervous system. 
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